Experience of Isavuconazole as a Salvage Therapy in Chronic Pulmonary Fungal Disease

Background: Instances of resistant fungal infection are rising in pulmonary disease, with limited therapeutic options. Therapeutic drug monitoring of azole antifungals has been necessary to ensure safety and efficacy but is considered unnecessary for the newest triazole isavuconazole. Aims: To chara...

Descripción completa

Detalles Bibliográficos
Autores principales: Nwankwo, Lisa, Gilmartin, Desmond, Matharu, Sheila, Nuh, Ali, Donovan, Jackie, Armstrong-James, Darius, Shah, Anand
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9029347/
https://www.ncbi.nlm.nih.gov/pubmed/35448593
http://dx.doi.org/10.3390/jof8040362

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9029347/
https://www.ncbi.nlm.nih.gov/pubmed/35448593
http://dx.doi.org/10.3390/jof8040362

Ejemplares similares